Pure Global
NCT06419478

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

Exploring Early Postoperative Core Symptoms in Chinese Patients With Primary Liver Cancer: a Cross-sectional and Longitudinal Network Analysis
Mengmeng Yuan·ClinicalTrials.gov·otherTerminated
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical Procedures,Importance of Identifying Core Symptoms for Improving Symptom Management in PLC Patients,Application of Network Analysis as a Crucial Component of Cancer Care
Drug/Device/Intervention
postoperative symptoms
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Mengmeng Yuan
Funder
Anhui Medical University
Location
Hefei, China
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2021
End date
Sep 01, 2022
Enrollment
249 participants
Primary outcome

MD Anderson Symptom Inventory

Summary

Patients with primary liver cancer (PLC) experience a range of symptoms in the early
 postoperative period. Symptoms include cancer-related symptoms and adverse effects of
 treatment. Exploring the core symptoms and their dynamics in the early post-hepatectomy
 patients may help provide better symptom management programs. The purpose of this study was
 to identify the core symptoms in early post-hepatectomy patients and to explore the
 trajectory of their dynamics. During the period from March 2021 to September 2022, a total of
 281 patients diagnosed with PLC and undergoing radical curative surgery were recruited from
 the hepatobiliary surgery departments of two hospitals in Eastern China, among whom 249
 individuals (88.60%) agreed to participate in the study. A comprehensive symptom assessment
 was administered to the patients 1-2 days after surgery (T1) and 1-2 days before discharge
 (T2). Network analysis was used to identify core symptoms in early post-hepatectomy patients
 based on symptom severity.

ICD-10 classifications
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ductsMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Liver cell carcinoma
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06419478
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06419478 through Pure Global AI's free database. This phase not specified trial is sponsored by Mengmeng Yuan and is currently Terminated. The study focuses on Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical Procedures,Importance of Identifying Core Symptoms for Improving Symptom Management in PLC Patients,Application of Network Analysis as a Crucial Component of Cancer Care. Target enrollment is 249 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.